Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre-Antoine Bonnet

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
The Analyst|January 9, 2020
An in-line enzymatic microreactor for the middle-up analysis of monoclonal antibodies by capillary electrophoresisMeriem Dadouch, Yoann Ladner, Claudia Bich, et al.
European Journal of Medicinal Chemistry|March 24, 2020
Agonist and antagonist ligands of toll-like receptors 7 and 8: Ingenious tools for therapeutic purposesCindy Patinote, Nour Bou Karroum, Georges Moarbess, et al.
International Journal of Molecular Sciences|July 27, 2024
Uncovering the Molecular Pathways Implicated in the Anti-Cancer Activity of the Imidazoquinoxaline Derivative EAPB02303 Using a <i>Caenorhabditis elegans</i> ModelPerla Makhoul, Simon Galas, Stéphanie Paniagua-Gayraud, et al.
Toxicology|December 14, 2004
Qualitative and quantitative evaluation of a local lymph node assay based on ex vivo interleukin-2 productionPhilippe Azam, Jean-Luc Peiffer, Jean-Claude Ourlin, et al.
European Journal of Medicinal Chemistry|March 13, 2009
New imidazo[1,2-a]quinoxaline derivatives: synthesis and in vitro activity against human melanomaCarine Deleuze-Masquefa, Georges Moarbess, Sonia Khier, et al.
Frontiers in Immunology|March 26, 2021
Imiquimod Targets Toxoplasmosis Through Modulating Host Toll-Like Receptor-MyD88 SignalingMaguy Hamie, Rania Najm, Carine Deleuze-Masquefa, et al.
Journal of Separation Science|April 29, 2009
Quantitation of imidazo[1,2-a]quinoxaline derivatives in human and rat plasma using LC/ESI-MSSonia Khier, Georges Moarbess, Carine Deleuze-Masquefa, et al.
Analytical Chemistry|October 18, 2012
Characterization of a new anticancer agent, EAPB0203, and its main metabolites: nuclear magnetic resonance and liquid chromatography-mass spectrometry studiesFlorian Lafaille, Bernard Banaigs, Nicolas Inguimbert, et al.
Plos Neglected Tropical Diseases|November 22, 2018
EAPB0503: An Imiquimod analog with potent in vitro activity against cutaneous leishmaniasis caused by Leishmania major and Leishmania tropicaRana El Hajj, Hanady Bou Youness, Laurence Lachaud, et al.
Bioorganic & Medicinal Chemistry|June 3, 2008
In vitro and in vivo anti-tumoral activities of imidazo[1,2-a]quinoxaline, imidazo[1,5-a]quinoxaline, and pyrazolo[1,5-a]quinoxaline derivativesGeorges Moarbess, Carine Deleuze-Masquefa, Vanessa Bonnard, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
The Analyst|January 9, 2020
An in-line enzymatic microreactor for the middle-up analysis of monoclonal antibodies by capillary electrophoresisMeriem Dadouch, Yoann Ladner, Claudia Bich, et al.
European Journal of Medicinal Chemistry|March 24, 2020
Agonist and antagonist ligands of toll-like receptors 7 and 8: Ingenious tools for therapeutic purposesCindy Patinote, Nour Bou Karroum, Georges Moarbess, et al.
International Journal of Molecular Sciences|July 27, 2024
Uncovering the Molecular Pathways Implicated in the Anti-Cancer Activity of the Imidazoquinoxaline Derivative EAPB02303 Using a <i>Caenorhabditis elegans</i> ModelPerla Makhoul, Simon Galas, Stéphanie Paniagua-Gayraud, et al.
Toxicology|December 14, 2004
Qualitative and quantitative evaluation of a local lymph node assay based on ex vivo interleukin-2 productionPhilippe Azam, Jean-Luc Peiffer, Jean-Claude Ourlin, et al.
European Journal of Medicinal Chemistry|March 13, 2009
New imidazo[1,2-a]quinoxaline derivatives: synthesis and in vitro activity against human melanomaCarine Deleuze-Masquefa, Georges Moarbess, Sonia Khier, et al.
Frontiers in Immunology|March 26, 2021
Imiquimod Targets Toxoplasmosis Through Modulating Host Toll-Like Receptor-MyD88 SignalingMaguy Hamie, Rania Najm, Carine Deleuze-Masquefa, et al.
Journal of Separation Science|April 29, 2009
Quantitation of imidazo[1,2-a]quinoxaline derivatives in human and rat plasma using LC/ESI-MSSonia Khier, Georges Moarbess, Carine Deleuze-Masquefa, et al.
Analytical Chemistry|October 18, 2012
Characterization of a new anticancer agent, EAPB0203, and its main metabolites: nuclear magnetic resonance and liquid chromatography-mass spectrometry studiesFlorian Lafaille, Bernard Banaigs, Nicolas Inguimbert, et al.
Plos Neglected Tropical Diseases|November 22, 2018
EAPB0503: An Imiquimod analog with potent in vitro activity against cutaneous leishmaniasis caused by Leishmania major and Leishmania tropicaRana El Hajj, Hanady Bou Youness, Laurence Lachaud, et al.
Bioorganic & Medicinal Chemistry|June 3, 2008
In vitro and in vivo anti-tumoral activities of imidazo[1,2-a]quinoxaline, imidazo[1,5-a]quinoxaline, and pyrazolo[1,5-a]quinoxaline derivativesGeorges Moarbess, Carine Deleuze-Masquefa, Vanessa Bonnard, et al.
Pageof 4